Cathie Wood’s Takeda Pharmaceutical TAK Stock Holding History

Cathie Wood’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,862,379	Closed	-$107M	–	384
2021 Q4	$107M	Sell	7,862,379 -5,639,271	-42%	-$79.1M	0.32%	55
2021 Q3	$221M	Sell	13,501,650 -1,991,347	-13%	-$33.4M	0.53%	42
2021 Q2	$261M	Sell	15,492,997 -3,224,147	-17%	-$54.9M	0.49%	53
2021 Q1	$342M	Buy	18,717,144 +10,098,979	+117%	+$182M	0.68%	46
2020 Q4	$157M	Buy	8,618,165 +7,461,868	+645%	+$131M	0.42%	59
2020 Q3	$20.6M	Buy	+1,156,297	New	+$21.1M	0.12%	89

Other funds holding TAK

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Cathie Wood's TAK Position: Q1 2022 in Review

Cathie Wood sold out of Takeda Pharmaceutical (TAK) in Q1 2022, closing a stake of 7,862,379 shares — an estimated $107M sold.

Cathie Wood first reported a position in TAK in Q3 2020 and held it in 6 quarters. The position peaked at $342M in Q1 2021. 288 funds tracked by Wall St. Rank hold TAK as of Q1 2022.

Cathie Wood reported no remaining Takeda Pharmaceutical position as of Q1 2022 after selling out during the quarter.
Cathie Wood sold 7,862,379 Takeda Pharmaceutical shares in Q1 2022, an estimated $107M.
Cathie Wood first reported a position in Takeda Pharmaceutical in Q3 2020 and held it in 6 quarters.
Cathie Wood's Takeda Pharmaceutical position peaked at $342M in Q1 2021.
288 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2022.

Based on ARK Investment Management's 13F filing for Q1 2022, filed 19 Apr 2022.